Joe Lomax

Joe has worked at the University of Plymouth in the medical statistics group since completing his bachelor’s degree in 2017. He has worked on the DQASS project since starting his current role as a research assistant and helps to produce the six monthly DQASS feedback reports.

Nuchal translucency measurements of less than 1.0 mm are valid

Joe Lomax and Rebecca Al-Ausi, 18 December 2020 - NHS Fetal Anomaly Screening Programme

Reporting nuchal translucency (NT) measurements of less than 1.0 mm are acceptable in the NHS Fetal Anomaly Screening Programme (FASP).

The PHE Screening team

Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.

Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.

If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.

Categories

Useful links

• Screening helpdesk
• Introduction to population screening e-learning
• Professional information (GOV.UK)
• Public information (NHS.UK)
• Simple PDF leaflets for printing
• Screening QA Service (SQAS)
• Education and training
• UK National Screening Committee

Blog tags

accessible information (116) Annual call (2) annual reports and updates (42) antenatal screening (165) artificial intelligence (4) blog news (20) call and recall (1) consultations (20) Coronavirus recovery (6) CPD and qualifications (74) data and KPIs (69) diagnostic testing (10) digital invitations (40) e-learning (31) easy read information (2) events and courses (77) failsafe (20) FIT (7) helpdesk (8) HPV (24) incidents (9) inequalities (97) information governance (6) IT systems (41) laboratories (32) monthly roundup (36) newborn screening (157) NIPT (19) primary care (15) public information and informed choice (148) quality improvement (98) research and audit (40) SCID (8) screening benefits and risks (38) shared learning (112) standards (47) STFYAYB (2) views from the front line (68) vision screening (5) workforce (46)

Comments and moderation

Read our guidelines

Recent posts

• Changes ahead for the national screening system 30 September 2021
• What we blogged about in August and September 2021 30 September 2021
• New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021

Follow us on social media

• PHE Screening on Twitter